📋 Product Overview Table
| 🌟 Parameter | 🔍 Details |
|---|---|
| 🧬 Active Ingredient | Cyclophosphamide |
| 💊 Indication | Cancer treatment (lymphoma, leukemia, breast cancer), nephrotic syndrome |
| 🇺🇸 US Brand Equivalent | Cytoxan |
| 🏭 Manufacturer | Zydus Cadila Pharma |
| 📦 Packaging | 10 tablets in 1 strip |
| 💪 Strength | 50 mg |
| 🚚 Delivery Time | 6–15 days (Ships to US, UK, Australia) |
🧬 What is Endoxan 50 mg?
Endoxan 50 mg by Zydus Cadila Pharma is a cytotoxic chemotherapy drug containing Cyclophosphamide, used to treat various types of cancer, including leukemia, lymphoma, breast cancer, ovarian cancer, and multiple myeloma. It is also prescribed off-label in autoimmune diseases like nephrotic syndrome and systemic lupus erythematosus.
Cyclophosphamide belongs to the class of alkylating agents that work by interfering with the growth of cancer cells, ultimately leading to their destruction. It can be administered orally or via injection and is often used in combination with other chemotherapeutic agents.
Endoxan is part of many standard chemotherapy regimens worldwide due to its versatility and effectiveness. It must be taken under close medical supervision due to potential bone marrow suppression and immunosuppression.
🎬 Educational Video Placeholder
🩺 Doctor’s Expert Commentary
Dr. Meenal Joshi, Oncologist:
“Cyclophosphamide remains one of the cornerstone drugs in oncology. Endoxan by Zydus Cadila offers reliable bioavailability and is often part of first-line treatment protocols. Close monitoring is essential for balancing efficacy and toxicity.”
💉 Dosage & Administration
| 📄 Indication | 💊 Dosage Example | ✏️ Administration Notes |
|---|---|---|
| Breast Cancer | 100–200 mg/m² daily (cyclic use) | Often combined with other chemo agents |
| Non-Hodgkin’s Lymphoma | 750 mg/m² IV on Day 1 (every 21d) | Oral version: 50–100 mg daily |
| Nephrotic Syndrome | 2–3 mg/kg/day orally | Short-term therapy in resistant cases |
Always follow personalized oncologist-prescribed regimens.
⚠️ Side Effects, Warnings & Storage
- Common Side Effects: Nausea, vomiting, hair loss, low white cell count
- Serious Effects: Hemorrhagic cystitis, cardiotoxicity, infertility
- Monitoring: Regular CBCs, liver/kidney function tests advised
- Storage: Store below 25°C in a dry place, away from sunlight
🌍 Global Availability
| 🌐 Country | 🚚 Shipping Available | 💵 Estimated Price (10 tablets) | 📜 Prescription Required |
|---|---|---|---|
| 🇺🇸 USA | ✅ Yes | $25–35 | Yes |
| 🇬🇧 UK | ✅ Yes | £18–25 | Yes |
| 🇦🇺 Australia | ✅ Yes | AUD 40–55 | Yes |
🔗 Related Indian Alternatives (Same Therapeutic Category)
| 💊 Product Name | 🏭 Manufacturer | 🔗 Link |
|---|---|---|
| Cycloxan 50 mg | Zydus Cadila | Cycloxan 50 mg |
| Cytomid 250 mg | Cipla Ltd. | Cytomid 250 mg |
| Lenmid 5 mg | Natco Pharma | Lenmid 5 mg |
| Imutrex 2.5 mg | Cipla Ltd. | Imutrex 2.5 mg |
| Zecyte 250 mg | Cipla Ltd. | Zecyte 250 mg |
📚 Trusted Medical References
⚠️ Medical Disclaimer
This content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed oncologist before starting chemotherapy.

